TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
SBM Life Science AB
Closing information (x1000 DKK)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
130,844
|
116,756
|
145,948 |
| Financial expenses |
2,133
|
3,936
|
3,615 |
| Earnings before taxes |
491
|
-882
|
2,870 |
| EBITDA |
2,620
|
2,490
|
6,121 |
| Total assets |
80,950
|
67,991
|
113,588 |
| Current assets |
80,421
|
67,293
|
112,929 |
| Current liabilities |
69,601
|
57,204
|
101,410 |
| Equity capital |
11,349
|
10,788
|
12,179 |
| - share capital |
33
|
32
|
34 |
| Employees (average) |
15
|
18
|
19 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
14.0%
|
15.9%
|
10.7% |
| Turnover per employee |
8,723
|
6,486
|
7,681 |
| Profit as a percentage of turnover |
0.4%
|
-0.8%
|
2.0% |
| Return on assets (ROA) |
3.2%
|
4.5%
|
5.7% |
| Current ratio |
115.5%
|
117.6%
|
111.4% |
| Return on equity (ROE) |
4.3%
|
-8.2%
|
23.6% |
| Change turnover |
12,111
|
-22,272
|
7,687 |
| Change turnover % |
10%
|
-16%
|
6% |
| Chg. No. of employees |
-3
|
-1
|
-8 |
| Chg. No. of employees % |
-17%
|
-5%
|
-30% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.